Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”

The following sentence: Furthermore, miR-25 one month after diagnosis was positively associated with residual beta-cell function (P=0.0037), and negatively associated with glycaemic control (HbA1c) (P=0.0035) 3 months after disease onset, should replace this sentence in the abstract of the existing paper: Furthermore, we identified miR-25 as negatively associated with residual beta-cell function (est.: −0.12, P=0.0037), and positively associated with glycaemic control (HbA1c) (est.: 0.11, P=0.0035) 3 months after onset.